Adam Parslow

Baker Heart and Diabetes Institute — Australia

Medicine · Health Sciences

15h-index1.1kcitations66works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(21), Monoclonal and Polyclonal Antibodies Research(20), Glycosylation and Glycoproteins Research(10), Genomics and Phylogenetic Studies(9), Machine Learning in Bioinformatics(9)

Publications66 total

Balcinrenone shows a unique regulation of potassium excretion in streptozotocin-induced diabetes in male mice
Endocrinology·2026
Better reporting is better science: Community-defined minimal reporting requirements for light microscopy
The Journal of Cell Biology·2026
CD14 Blockade Modulates Macrophage-Mediated Immunological Injury in a Translational Model of Reperfused ST-Segment Elevation Myocardial Infarction
JACC Basic to Translational Science·2025Open Access
Data from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025· 1 citedOpen Access
Figure S7 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Supplementary Table 2 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Figure S8 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Figure S4 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Supplementary Table 1 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Figure S6 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Figure S1 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Figure S5 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Supplementary Data from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Figure S2 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Figure S3 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
Molecular Cancer Therapeutics·2025· 1 citedOpen Access
CD14 blockade in a translational model of reperfused ST-elevation myocardial infarction with key clinical features.
2025Open Access
Distinct functional and molecular profiles between physiological and pathological atrial enlargement offer potential new therapeutic opportunities for atrial fibrillation
Clinical Science·2024· 6 citedOpen Access
An Anti-VEGF-B Antibody Reduces Abnormal Tumor Vasculature and Enhances the Effects of Chemotherapy
Cancers·2024· 11 citedOpen Access
Community-developed checklists for publishing images and image analyses.
PubMed·2023· 5 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Andrew M. Scott(20), Hui Gan(14), Robert J. Bryson‐Richardson(10), Sagun Parakh(10), Ingrid J.G. Burvenich(10), Angela Rigopoulos(10), Caitlin Williams(8), Nancy Guo(8), Christian Wichmann(8), Peter W. Janes(7), Fiona E. Scott(7), Matthias Ernst(6), Manjula Algama(6), Edward Tasker(6), Jonathan M. Keith(6), Nhi Huynh(6), Deliang Cao(6), Benjamin Gloria(6), Carmel Murone(6), Clare Senko(6)